Voyageur Pharmaceuticals Ltd - Asset Resilience Ratio

Latest as of May 2024: 0.15%

Voyageur Pharmaceuticals Ltd (VM) has an Asset Resilience Ratio of 0.15% as of May 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CA$3.50K

≈ $2.53K USD Cash + Short-term Investments

Total Assets

CA$2.33 Million

≈ $1.68 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2023)

This chart shows how Voyageur Pharmaceuticals Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Voyageur Pharmaceuticals Ltd to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Voyageur Pharmaceuticals Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see VM company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$3.50K	0.15%
Total Liquid Assets	CA$3.50K	0.15%

Asset Resilience Insights

Limited Liquidity: Voyageur Pharmaceuticals Ltd maintains only 0.15% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Voyageur Pharmaceuticals Ltd Industry Peers by Asset Resilience Ratio

Compare Voyageur Pharmaceuticals Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Hisoar Pharmaceutical Co Ltd SHE:002099	Drug Manufacturers - Specialty & Generic	0.20%
Celltrion Pharm Inc KQ:068760	Drug Manufacturers - Specialty & Generic	12.49%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Heilongjiang ZBD Pharmaceutical Co Ltd SHG:603567	Drug Manufacturers - Specialty & Generic	0.00%
Zhejiang Anglikang Pharmaceutical Co Ltd Class A SHE:002940	Drug Manufacturers - Specialty & Generic	9.11%

Annual Asset Resilience Ratio for Voyageur Pharmaceuticals Ltd (2021–2023)

The table below shows the annual Asset Resilience Ratio data for Voyageur Pharmaceuticals Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-11-30	0.00%	CA$3.50 ≈ $2.53	CA$2.16 Million ≈ $1.57 Million	0.00pp
2022-11-30	0.00%	CA$5.95 ≈ $4.30	CA$2.10 Million ≈ $1.52 Million	+0.00pp
2021-11-30	0.00%	CA$5.95 ≈ $4.30	CA$2.57 Million ≈ $1.86 Million	--

pp = percentage points

About Voyageur Pharmaceuticals Ltd

V:VM Canada Drug Manufacturers - Specialty & Generic

Market Cap

$16.79 Million

CA$23.22 Million CAD

Market Cap Rank

#25602 Global

#1004 in Canada

Share Price

CA$0.13

Change (1 day)

+0.00%

52-Week Range

CA$0.08 - CA$0.20

All Time High

CA$0.34